Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 5497

BillFederalHouseIn Committee
Conditional Approval Act
About This Bill
Committee
Latest Action · December 20, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
December 19, 2019
Cosponsors (2)
0D 2R
View PDF ↗

Summary

Highlight any text to annotate
Conditional Approval Act This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.